COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

- Furlong, Eliska, Kotecha, Rishi S., Phillips, Marianne B., Padhye, Bhavna, Dalla-Pozza, Luciano, Alvaro, Frank, Fraser, Christopher J., Nicholls, Wayne, Clark, Julia E., O'Connor, Matthew, Saxon, Benjamin R., Tapp, Heather, Conyers, Rachel, Heath, John, Hunter, SE, Tsui, K, Winstanley, M, Lyver, A, Best, EJ, Wadia, U, Yeoh, D, Blyth, CC, Gottardo, NG, O'Brien, Tracey A., Hansford, Jordan R., Super, Leanne, Downie, Peter, Eisenstat, David D., Haeusler, Gabrielle, McMullan, Brendan

Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia

- Sutton, Rosemary, Shaw, Peter J., Revesz, Tamas, Trahair, Toby N., Dalla-Pozza, Luciano, Marshall, Glenn M., O'Brien, Tracey A., Venn, Nicola C., Law, Tamara, Dissanayake, Anuruddhika, Kilo, Tatjana, Haber, Michelle, Norris, Murray D., Fraser, Chris, Alvaro, Frank

Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand children's haematology oncology group and the Australasian bone marrow transplant recipient registry

- Mitchell, Richard, Nivison-Smith, Ian, O'Brien, Tracey A., Anazodo, Antoinette, Tiedemann, Karin, Shaw, Peter, Teague, Lochie, Fraser, Chris, Carter, Tina, Tapp, Heather, Alvaro, Frank